SPIRIVA HANDIHALER Rx

Select the drug indication to add to your list

SPIRIVA HANDIHALER

Asthma/COPD
Only 4 drugs may be compared at once

Generic Name and Formulations:

Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device.

Select therapeutic use:

Indications for SPIRIVA HANDIHALER:

Long-term maintenance treatment of bronchospasm due to COPD, including chronic bronchitis and emphysema. To reduce exacerbations of COPD.

Adult:

2 inh of one capsule contents (18mcg) once daily, using HandiHaler inhalation device. Max: 2 inh/24hrs. Do not swallow caps.

Children:

Not established.

Contraindications:

Allergy to ipratropium.

Warnings/Precautions:

Not for the relief of acute symptoms. Discontinue if immediate hypersensitivity reactions (eg, angioedema) or paradoxical bronchospasm occurs; consider alternative therapy. Monitor for signs/symptoms of worsening narrow-angle glaucoma or worsening urinary retention (esp. GI or GU obstruction). Moderate-to-severe renal impairment; monitor for anticholinergic effects. Allergy to atropine or its derivatives; monitor. HandiHaler: avoid getting powder into eyes; or allergy to milk proteins. Pregnancy. Labor & delivery. Nursing mothers.

Interactions:

Avoid other anticholinergics.

See Also:

SPIRIVA RESPIMAT

Pharmacological Class:

Long-acting anticholinergic.

Adverse Reactions:

Upper respiratory tract infection, dry mouth, sinusitis, pharyngitis, bronchitis, cough, headache, non-specific chest pain, UTI, dyspepsia, rhinitis, other anticholinergic effects (eg, urinary retention, constipation, dysuria, tachycardia, blurred vision, glaucoma); paradoxical bronchospasm.

Generic Availability:

NO

How Supplied:

HandiHaler (caps w. inh device)—5, 30, 90; Respimat (cartridge w. inh device)—4g (60 inh)